GFH fundamentals.
▸ Extracted from the filings themselves — every figure links to the exact page it came from. Latest validated period: 2025-12-31. ← back to GFH
Headline trend
last 4 filed quarters| Metric | Q1 ’25 | Q2 ’25 | Q3 ’25 | Q4 ’25 |
|---|---|---|---|---|
| Net profit | USD 30.69mn p.5 | USD 39.02mn p.6 | USD 35.23mn p.6 | — |
| Total assets | USD 11.59bn p.4 | USD 12.36bn p.4 | USD 12.26bn p.4 | USD 12.20bn p.16 |
| Total equity | USD 1.07bn p.4 | USD 1.13bn p.4 | USD 1.17bn p.4 | USD 1.14bn p.16 |
▸ Flows (revenue, net profit, operating cash flow) are the discrete quarter; balance-sheet lines are point-in-time.
Full statements
latest filed periodBalance sheet
as of 2025-12-31| cash | USD 249,230,000 | p.16 |
| Treasury portfolio | USD 5,291,923,000 | p.16 |
| Financing contracts | USD 2,529,917,000 | p.16 |
| Proprietary assets | USD 3,075,844,000 | p.16 |
| Receivables and other assets | USD 1,000,405,000 | p.16 |
| Property and equipment | USD 54,796,000 | p.16 |
| total_assets | USD 12,202,115,000 | p.16 |
| Clients accounts | USD 335,400,000 | p.16 |
| Placements from financial institutions | USD 3,044,067,000 | p.16 |
| Placements from non-financial institutions and individuals | USD 1,280,091,000 | p.16 |
| Term financing | USD 2,523,516,000 | p.16 |
| Other liabilities | USD 563,891,000 | p.16 |
| total_liabilities | USD 7,746,965,000 | p.16 |
| QUASI EQUITY | USD 3,317,929,000 | p.16 |
| Share capital | USD 1,015,637,000 | p.16 |
| Treasury shares | USD -158,578,000 | p.16 |
| Statutory reserve | USD 73,379,000 | p.16 |
| Investment fair value reserve | USD -27,370,000 | p.16 |
| Retained earnings | USD 107,358,000 | p.16 |
| Share grant reserve | USD 10,342,000 | p.16 |
| Total equity attributable to shareholders of the Bank | USD 1,020,768,000 | p.16 |
| Non-controlling interests | USD 116,453,000 | p.16 |
| total_equity | USD 1,137,221,000 | p.16 |
| total_liabilities_and_equity | USD 12,202,115,000 | p.16 |
Cash flow
full year to 2025-12-31| Placements with financial institutions (original maturities of 3 months or less) | USD 976,942,000 | p.22 |
| Cash and balances with banks (excluding CBB Reserve balance and restricted cash) (note 6) | USD 155,951,000 | p.22 |
| Cash and cash equivalents at 31 December | USD 1,132,893,000 | p.22 |
| Cash and cash equivalents at 1 January* | USD 1,165,081,000 | p.22 |
| Net decrease in cash and cash equivalents | USD -32,188,000 | p.22 |
| Net cash used in financing activities | USD -329,080,000 | p.22 |
| (Purchase) / sale of treasury shares, net | USD -78,086,000 | p.22 |
| dividends_paid | USD -93,858,000 | p.22 |
| Finance expense paid | USD -538,589,000 | p.22 |
| Term financing, net | USD 381,453,000 | p.22 |
| Net cash (used in) / from investing activities | USD -151,416,000 | p.22 |
| Sale of treasury portfolio, net | USD 143,235,000 | p.22 |
| (Purchase) / Sale of proprietary assets, net | USD -294,972,000 | p.22 |
| Clients accounts | USD -177,332,000 | p.22 |
| Profit for the year | USD 145,504,000 | p.22 |
| Treasury and proprietary assets | USD -563,755,000 | p.22 |
| Foreign exchange (gain) / loss | USD -4,535,000 | p.22 |
| Finance expense | USD 506,752,000 | p.22 |
| Impairment allowances | USD 26,846,000 | p.22 |
| Depreciation and amortisation | USD 14,637,000 | p.22 |
| Placements with financial institutions (original maturities of more than 3 months) | USD 95,248,000 | p.22 |
| Financing contracts | USD -307,803,000 | p.22 |
| Receivables and other assets | USD -156,003,000 | p.22 |
| CBB reserve and other assets | USD -8,513,000 | p.22 |
| Placements from financial institutions | USD 599,608,000 | p.22 |
| Placements from non-financial institutions and individuals | USD -112,713,000 | p.22 |
| Quasi equity | USD 337,112,000 | p.22 |
| Other liabilities | USD 53,256,000 | p.22 |
| ocf | USD 448,309,000 | p.22 |
| Sale of property, plant and equipment, net | USD 321,000 | p.22 |
Income statement
full year to 2025-12-31| Wealth and investment management | USD 174,121,000 | p.17 |
| Credit & financing | USD 155,156,000 | p.17 |
| Treasury and proprietary | USD 390,262,000 | p.17 |
| total_income | USD 719,539,000 | p.17 |
| Other operating expenses | USD 267,490,000 | p.17 |
| Finance expense | USD 279,368,000 | p.17 |
| Impairment allowances | USD 27,177,000 | p.17 |
| Total expenses | USD 574,035,000 | p.17 |
| net_income | USD 145,504,000 | p.17 |
| Shareholders of the Bank | USD 140,110,000 | p.17 |
| Non-controlling interests | USD 5,394,000 | p.17 |
| Basic and diluted earnings per share (US cents) | USD 3,920 | p.17 |
| net_income | USD 145,504,000 | p.18 |
| Fair value changes on debt investments carried at fair value through OCI | USD 1,355,000 | p.18 |
| Fair value changes on equity investments carried at fair value through OCI | USD 13,043,000 | p.18 |
| Equity-accounted investees - share of OCI | USD 26,189,000 | p.18 |
| Other comprehensive income for the year | USD 40,587,000 | p.18 |
| Total comprehensive income | USD 186,091,000 | p.18 |
| Shareholders of the Bank | USD 179,475,000 | p.18 |
| Non-controlling interests | USD 6,616,000 | p.18 |